Patents

US 12708609 B2: Methods and compositions for treating inflammation

Granted
2026-08-18
Filed
2023-11-22 application 18517596
Type
Utility · 6 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

Disclosed herein are methods and compositions for treating neutrophil-mediated inflammation by targeting, in any combination, the pro-inflammatory MRP2/HXA3 pathway and/or the anti-inflammatory P-gp/endocannabinoid pathway and/or the anti-inflammatory MRP 1/L-AMEND pathway, comprising administering to the subject a therapeutically effective amount of (a) one or more first compound that inhibits the activity and/or level of one or more of multidrug resistance protein 2 (MRP2) and hepoxilin A3 (HXA3) synthase, and/or (b) one or more second compound that increases the level and/or activity of one or more N-acylethanolamines (NAEs), and/or (c) one or more third compound that increases the level and/or activity of multidrug resistance protein 1 (MRP1), wherein the therapeutic amount of the first, second, and third compounds reduces migration of neutrophils into the target tissue.

Source: PTBLXML, file of 2026-08-18 (ipgb20260818.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
UNIVERSITY OF BATH 32 patentsForeign company or organizationBath, GBPTBLXML, file of 2026-08-18
UNIVERSITY OF MASSACHUSETTS 1,152 patentsUS company or organizationBoston, MAUNIVERSITY OF MASSACHUSETTS Federal lobbying client EXACT high confidence: identical full name and statePTBLXML, file of 2026-08-18

Inventors

InventorPlacePatentsPerson pageSource
Randall MrsnyLos Altos Hills, CAPTBLXML, file of 2026-08-18
Beth McCormickHaverhill, MA4PTBLXML, file of 2026-08-18
Roland Ellwood DolleAshland, MAPTBLXML, file of 2026-08-18

CPC categories

SubclassCategoryFirst groupSource
A61KPreparations for medical, dental or toiletry purposesA61K31/195PTBLXML, file of 2026-08-18

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2024-03-06Assignment
Assignment of assignor's interest
BACAINN BIOTHERAPEUTICS LTD signed 2019-04-30UNIVERSITY OF MASSACHUSETTS BOSTON, MA66662/761PASDL, file of 2026-08-13
2024-03-06Assignment
Assignment of assignor's interest
BACAINN BIOTHERAPEUTICS LTD. signed 2019-10-01UNIVERSITY OF BATH BATH66662/368PASDL, file of 2026-08-13
2024-02-26Assignment
Assignment of assignor's interest
MCCORMICK, BETH A signed 2019-03-20UNIVERSITY OF MASSACHUSETTS BOSTON, MA66560/808PASDL, file of 2026-08-13
2024-02-26Assignment
Assignment of assignor's interest
MRSNY, RANDALL signed 2019-04-27UNIVERSITY OF BATH BATH66560/704PASDL, file of 2026-08-13
2024-02-26Assignment
Assignment of assignor's interest
DOLLE, ROLAND ELLWOOD signed 2017-07-21BACAINN BIOTHERAPEUTICS, LTD GEORGE TOWN66560/230PASDL, file of 2026-08-13

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.